(Q33872836)

29 July 2017

title

Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease (English)

1 reference

29 July 2017

main subject

essential hypertension

1 reference

Ryan S Friese

1

1 reference

29 July 2017

Fangwen Rao

2

1 reference

29 July 2017

Srikrishna Khandrika

3

1 reference

29 July 2017

Brenda Thomas

4

1 reference

29 July 2017

Michael G Ziegler

5

1 reference

29 July 2017

Geert W Schmid-Schönbein

6

1 reference

29 July 2017

Daniel T O'Connor

7

1 reference

29 July 2017

publication date

1 October 2009

1 reference

Clinical and Experimental Hypertension

29 July 2017

published in

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

521-533

1 reference

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

Matrix metalloproteinases: useful and deleterious

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

Is hypertension an inflammatory process?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

Role of angiotensin II receptor blockers in atherosclerotic plaque stability.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat.

5 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960802668730

The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960802668730

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

21 January 2018

3 references

https://api.crossref.org/works/10.3109%2F10641960802668730

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875383

29 October 2018

12 December 2020

ACE inhibitors to block MMP-9 activity: new functions for old inhibitors.

1 reference

https://api.crossref.org/works/10.3109%2F10641960802668730

Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960802668730

Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy

21 January 2018

1 reference

12 December 2020

Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors

1 reference

12 December 2020

Abnormalities of the extracellular degradation of collagen type I in essential hypertension

1 reference

12 December 2020

Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure

1 reference

12 December 2020

Increased levels of atherosclerosis markers in salt-sensitive hypertension

1 reference

12 December 2020

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

1 reference

12 December 2020

Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension

1 reference

12 December 2020

Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients

1 reference

12 December 2020

Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension

1 reference

12 December 2020

Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension

1 reference

12 December 2020

10.3109/10641960802668730

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference